These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18405840)

  • 21. [Application of high-throughput technologies in pharmaceutics].
    Bai XL; Gao YL
    Yao Xue Xue Bao; 2006 Jun; 41(6):487-92. PubMed ID: 16927820
    [No Abstract]   [Full Text] [Related]  

  • 22. [Strategy of molecular drug design: activity and druggability].
    Guo ZR
    Yao Xue Xue Bao; 2010 May; 45(5):539-47. PubMed ID: 20931752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM; Bernardo PH; Chai CL; Tong JC
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge-based chemoinformatic approaches to drug discovery.
    Ghose AK; Herbertz T; Salvino JM; Mallamo JP
    Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical property trends of marketed prodrugs.
    Landis MS
    Ther Deliv; 2013 Feb; 4(2):225-37. PubMed ID: 23343161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmaceutical significance of amorphous materials].
    Antal I; Zelkó R
    Acta Pharm Hung; 2008; 78(3):121-33. PubMed ID: 18986089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
    Erdemir D; Lee AY; Myerson AS
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular similarity based estimation of properties: a comparison of structure spaces and property spaces.
    Gute BD; Grunwald GD; Mills D; Basak SC
    SAR QSAR Environ Res; 2001 Feb; 11(5-6):363-82. PubMed ID: 11328710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploiting QSAR models in lead optimization.
    Gedeck P; Lewis RA
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):569-75. PubMed ID: 18600573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Working with small molecules: rules-of-thumb of "drug likeness".
    Zhang MQ
    Methods Mol Biol; 2012; 803():297-307. PubMed ID: 22065233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the chemical properties of drugs and FEMA/FDA notified GRAS chemical compounds used in the food industry.
    Sprous DG; Salemme FR
    Food Chem Toxicol; 2007 Aug; 45(8):1419-27. PubMed ID: 17368904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space.
    Vallianatou T; Giaginis C; Tsantili-Kakoulidou A
    Adv Exp Med Biol; 2015; 822():187-94. PubMed ID: 25416989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substructure mining using elaborate chemical representation.
    Kazius J; Nijssen S; Kok J; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):597-605. PubMed ID: 16562988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prediction of ADMET properties using structure information representations.
    Kier LB; Hall LH
    Chem Biodivers; 2005 Nov; 2(11):1428-37. PubMed ID: 17191944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.